BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8006945)

  • 1. Fumarate reductase of Helicobacter pylori--an immunogenic protein.
    Birkholz S; Knipp U; Lemma E; Kröger A; Opferkuch W
    J Med Microbiol; 1994 Jul; 41(1):56-62. PubMed ID: 8006945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.
    Ge Z
    Expert Opin Ther Targets; 2002 Apr; 6(2):135-46. PubMed ID: 12223076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and functional characterization of Helicobacter pylori fumarate reductase operon comprising three structural genes coding for subunits C, A and B.
    Ge Z; Jiang Q; Kalisiak MS; Taylor DE
    Gene; 1997 Dec; 204(1-2):227-34. PubMed ID: 9434188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A periplasmic flavoprotein in Wolinella succinogenes that resembles the fumarate reductase of Shewanella putrefaciens.
    Simon J; Gross R; Klimmek O; Ringel M; Kröger A
    Arch Microbiol; 1998 May; 169(5):424-33. PubMed ID: 9560424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
    Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of fumarate reductase from Wolinella succinogenes at 2.2 A resolution.
    Lancaster CR; Kröger A; Auer M; Michel H
    Nature; 1999 Nov; 402(6760):377-85. PubMed ID: 10586875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous production in Wolinella succinogenes and characterization of the quinol:fumarate reductase enzymes from Helicobacter pylori and Campylobacter jejuni.
    Mileni M; MacMillan F; Tziatzios C; Zwicker K; Haas AH; Mäntele W; Simon J; Lancaster CR
    Biochem J; 2006 Apr; 395(1):191-201. PubMed ID: 16367742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach.
    Ge Z; Feng Y; Dangler CA; Xu S; Taylor NS; Fox JG
    Microb Pathog; 2000 Nov; 29(5):279-87. PubMed ID: 11031122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumarate reductase: a target for therapeutic intervention against Helicobacter pylori.
    Mendz GL; Hazell SL; Srinivasan S
    Arch Biochem Biophys; 1995 Aug; 321(1):153-9. PubMed ID: 7639515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the respiratory chain of Helicobacter pylori.
    Chen M; Andersen LP; Zhai L; Kharazmi A
    FEMS Immunol Med Microbiol; 1999 Jun; 24(2):169-74. PubMed ID: 10378416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of neutral sphingomyelinase from Helicobacter pylori.
    Chan EC; Chang CC; Li YS; Chang CA; Chiou CC; Wu TZ
    Biochemistry; 2000 Apr; 39(16):4838-45. PubMed ID: 10769141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of Glu-C66 for menaquinol oxidation indicates transmembrane electrochemical potential generation by Wolinella succinogenes fumarate reductase.
    Lancaster CR; Gorss R; Haas A; Ritter M; Mäntele W; Simon J; Kröger A
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13051-6. PubMed ID: 11186225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterisation of monoclonal antibodies to heat-shock protein 60 of Helicobacter pylori.
    Yamaguchi H; Osaki T; Taguchi H; Hanawa T; Yamamoto T; Kamiya S
    J Med Microbiol; 1997 Oct; 46(10):819-24. PubMed ID: 9364137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease.
    Fujii R; Morihara F; Fukushima K; Oku T; Hifumi E; Uda T
    Biotechnol Bioeng; 2004 Jun; 86(7):737-46. PubMed ID: 15162449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to Helicobacter pylori excretory antigen and the cross reaction study.
    Sasidharan S; Uyub AM
    J Immunoassay Immunochem; 2009; 30(1):70-81. PubMed ID: 19117203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori.
    O'Toole PW; Logan SM; Kostrzynska M; Wadström T; Trust TJ
    J Bacteriol; 1991 Jan; 173(2):505-13. PubMed ID: 1987145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific identification of three low molecular weight membrane-associated antigens of Helicobacter pylori.
    Voland P; Weeks DL; Vaira D; Prinz C; Sachs G
    Aliment Pharmacol Ther; 2002 Mar; 16(3):533-44. PubMed ID: 11876708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of the subunits of the fumarate reductase complex of Vibrio succinogenes.
    Unden G; Kröger A
    Eur J Biochem; 1981 Dec; 120(3):577-84. PubMed ID: 7333282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Western blot analysis of serological response in Helicobacter pylori in acid peptic diseases.
    Chatha L; Ray P; Bhasin DK; Panigrahi D; Khanna T; Vaiphei K; Singh K; Singh H
    Indian J Med Res; 1997 Apr; 105():170-5. PubMed ID: 9145600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of catalase antibody in Helicobacter pylori infection].
    Kamishima Y
    Hokkaido Igaku Zasshi; 2000 Sep; 75(5):287-98. PubMed ID: 11070790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.